Biomarkers for severe allergic asthma in children: could they be useful to guide disease control and use of omalizumab? [electronic resource]
Producer: 20190222Description: 475-482 p. digitalISSN:- 1747-6356
- Anti-Asthmatic Agents -- economics
- Asthma -- drug therapy
- Biomarkers -- metabolism
- Cell Adhesion Molecules -- metabolism
- Cell Count
- Child
- Cost-Benefit Analysis
- Eosinophil Cationic Protein -- metabolism
- Eosinophil-Derived Neurotoxin -- metabolism
- Eosinophils -- metabolism
- Exhalation
- Humans
- Inflammation -- metabolism
- Nitric Oxide -- metabolism
- Omalizumab -- economics
- Phenotype
- Sputum -- metabolism
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.